González-Calle, Verónica http://orcid.org/0000-0002-5493-6707
Slack, Abigail
Keane, Niamh
Luft, Susan
Pearce, Kathryn E.
Ketterling, Rhett P.
Jain, Tania
Chirackal, Sintosebastian
Reeder, Craig
Mikhael, Joseph
Noel, Pierre
Mayo, Angela
Adams, Roberta H.
Ahmann, Gregory
Braggio, Esteban
Stewart, A. Keith
Bergsagel, P. Leif
Van Wier, Scott A.
Fonseca, Rafael
Funding for this research was provided by:
Fundación Española de Hematología y Hemoterapia-Janssen
Article History
Received: 28 April 2017
Accepted: 22 March 2018
First Online: 6 April 2018
Compliance with ethical standards
:
: Dr. Rafael Fonseca: Consulting with AMGEN, BMS, Celgene, Takeda, Bayer, Jansen, Novartis, Pharmacyclics, Sanofi and Merck. Member of the Scientific Advisory Board of Adaptive Biotechnologies. Mayo Clinic and Dr. Fonseca hold a patent for the prognostication of myeloma via FISH with annual income of about $2K dollars. There are no conflicts of interest declared by the rest of the authors.